Intelligence Platform

Patents

Browse 750 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 7888069

Plant-made west nile virus (WNV) vaccines, vectors and plant codon optimized sequences

The United States of America as represented by the Secretary of Argriculture · Granted Tue Feb 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7884178

Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nu

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 08 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 03 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7871985

Compositions and methods for inhibiting expression of factor VII gene

Alnylam Pharmaceuticals, Inc. · Granted Tue Jan 18 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7867500

Cofactor that modulates steroid receptor activities

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jan 11 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7867974

Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

granted patent

US 7863421

Polymer-factor VIII moiety conjugates

Nektar Therapeutics · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7863041

Rabies virus vector systems and compositions and methods thereof

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Jan 04 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7858749

Polymer-factor VIII moiety conjugates

Nektar Therapeutics · Granted Tue Dec 28 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 23 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7820181

Recovery of recombinant human parainfluenza virus type 2 (HPIV2) from cDNA and use of reco

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Oct 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776320

Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex

The Regents of the University of California · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776564

Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and method

Five Prime Therapeutics, Inc. · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7771715

Recombinant vector expressing multiple costimulatory molecules and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7771729

Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant adm

granted patent

US 7759304

Targeting complement factor H for treatment of diseases

The Regents of the University of Colorado · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7745406

Fibroblast growth factor (FGF23) polypeptides

Ludwig-Maximilians-Universitat Munchen Abeteilung Mediziniche Genetik · Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718428

Myeloid colony stimulating factor and uses thereof

HALOZYME, INC. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7717728

Electrical Connector

Advanced Connectek Inc. · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7718424

AAV4 vector and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7704509

Recovery of recombinant human parainfluenza virus type 1 (HPIV1) from cDNA and use of reco

The United States of America · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7658551

Optical fiber connector

Advanced Connectek Inc. · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7638134

Insertion sites in fowlpox vectors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Dec 29 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 24 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7618936

Methods for treating and diagnosing cancer with WNT inhibitory Factor-1 (WIF-1)

The Regents of the University of California · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7618623

Hybrid adeno-retroviral vector for the transfection of cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7605127

Truncated hepatocyte growth factor variant protein HGF/NK2

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted